Table 3 Summary of the risk factors for MRI-defined silent cerebral infarcts in sickle cell disease

Abboud et al. 2011* [19]

Arkuszewski et al. 2014 [20]

Armstrong et al. 1996** [12]

Asbeutah et al. 2014^○ [21]

Baldeweg et al. 2006 [22]

Bernaudin et al. 2000^ǂ [69]

Bernaudin et al. 2011^ǂ [23]

Bernaudin et al. 2015^ǂ [58]

de Blank et al. 2010 [24]

Brousse et al. 2017 [25]

Calvet et al. 2017 [27]

DeBaun et al. 2012 [70]

Farina et al. 2012 [60]

Jordan, Kassim et al. 2018 [71]

Jordan, Williams et al. 2018 *** [61]

Kinney et al. 1999 [72]

Kwiatkoswki et al. 2009 [6]

Marouf et al. 2003 ○ [67]

Melek et al. 2006 [38]

Miller et al. 2001** [11]

Nottage et al. 2016 [68]

Ogunsile et al. 2018*** [73]

Pegelow et al. 2001* [42]

Pegelow et al. 2002** [10]

Sarnaik et al. 2009*** [74]

Silva et al. 2009 [46]

Solomou et al. 2013 [47]

Strouse et al. 2009 [75]

Tewari et al. 2018 [49]

Van der Land et al. 2016 [52]

Wang et al. 2000*,** [64]

Wang et al. 2008 [55]

Zafeiriou et al. 2004 [57]